市場調査レポート：早漏防止薬の世界市場2023：セロトニン再取り込み阻害剤、ホスホジエステラーゼ5型阻害剤、局所麻酔薬、その他

• 英文タイトル：Global Anti-premature Ejaculation Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Anti-premature Ejaculation Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029「早漏防止薬の世界市場2023：セロトニン再取り込み阻害剤、ホスホジエステラーゼ5型阻害剤、局所麻酔薬、その他」（市場規模、市場予測）調査レポートです。

• レポートコード：MRC308GR11364
• 出版社/出版日：GlobalInfoResearch / 2023年8月
• レポート形態：英文、PDF、75ページ
• 納品方法：Eメール（2-3営業日）
• 産業分類：医薬品＆ヘルスケア

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Corporate User	￥783,000 (USD5,220)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

GlobalInfoResearchの最新の調査によると、世界の早漏防止薬の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。

このレポートは、世界の早漏防止薬市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 早漏防止薬の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため

早漏防止薬市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・セロトニン再取り込み阻害剤、ホスホジエステラーゼ5型阻害剤、局所麻酔薬、その他

用途別セグメント
・病院、小売薬局、クリニック、オンライン薬局

主要な市場プレーヤー
・Menarini Group、Ampio Pharmaceuticals Inc、Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd、AdvaCare

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、早漏防止薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な早漏防止薬メーカーの企業概要、2019年～2022年までの早漏防止薬の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な早漏防止薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別早漏防止薬の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの早漏防止薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での早漏防止薬市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および早漏防止薬の産業チェーンを掲載しています。
・第14、15章では、早漏防止薬の販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
– 早漏防止薬の概要
– 種類別分析（2018年vs2022年vs2029年）：セロトニン再取り込み阻害剤、ホスホジエステラーゼ5型阻害剤、局所麻酔薬、その他
– 用途別分析（2018年vs2022年vs2029年）：病院、小売薬局、クリニック、オンライン薬局
– 世界の早漏防止薬市場規模・予測
– 世界の早漏防止薬生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Menarini Group、Ampio Pharmaceuticals Inc、Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd、AdvaCare
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：セロトニン再取り込み阻害剤、ホスホジエステラーゼ5型阻害剤、局所麻酔薬、その他
・用途別分析2018年-2029年：病院、小売薬局、クリニック、オンライン薬局
・早漏防止薬の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・早漏防止薬のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・早漏防止薬のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・早漏防止薬の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・早漏防止薬の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Anti-premature Ejaculation Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-premature Ejaculation Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Serotonin Reuptake Inhibitors
1.3.3 Phosphodiesterase Type 5 Inhibitors
1.3.4 Local Anesthetic
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-premature Ejaculation Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Clinic
1.4.5 Online Pharmacy
1.5 Global Anti-premature Ejaculation Drug Market Size & Forecast
1.5.1 Global Anti-premature Ejaculation Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anti-premature Ejaculation Drug Sales Quantity (2018-2029)
1.5.3 Global Anti-premature Ejaculation Drug Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Menarini Group
2.1.1 Menarini Group Details
2.1.2 Menarini Group Major Business
2.1.3 Menarini Group Anti-premature Ejaculation Drug Product and Services
2.1.4 Menarini Group Anti-premature Ejaculation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Menarini Group Recent Developments/Updates
2.2 Ampio Pharmaceuticals Inc
2.2.1 Ampio Pharmaceuticals Inc Details
2.2.2 Ampio Pharmaceuticals Inc Major Business
2.2.3 Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Product and Services
2.2.4 Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Ampio Pharmaceuticals Inc Recent Developments/Updates
2.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
2.3.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Details
2.3.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Major Business
2.3.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Product and Services
2.3.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments/Updates
2.4 AdvaCare
2.4.1 AdvaCare Details
2.4.2 AdvaCare Major Business
2.4.3 AdvaCare Anti-premature Ejaculation Drug Product and Services
2.4.4 AdvaCare Anti-premature Ejaculation Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AdvaCare Recent Developments/Updates
3 Competitive Environment: Anti-premature Ejaculation Drug by Manufacturer
3.1 Global Anti-premature Ejaculation Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anti-premature Ejaculation Drug Revenue by Manufacturer (2018-2023)
3.3 Global Anti-premature Ejaculation Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anti-premature Ejaculation Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anti-premature Ejaculation Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Anti-premature Ejaculation Drug Manufacturer Market Share in 2022
3.5 Anti-premature Ejaculation Drug Market: Overall Company Footprint Analysis
3.5.1 Anti-premature Ejaculation Drug Market: Region Footprint
3.5.2 Anti-premature Ejaculation Drug Market: Company Product Type Footprint
3.5.3 Anti-premature Ejaculation Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Anti-premature Ejaculation Drug Market Size by Region
4.1.1 Global Anti-premature Ejaculation Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Anti-premature Ejaculation Drug Consumption Value by Region (2018-2029)
4.1.3 Global Anti-premature Ejaculation Drug Average Price by Region (2018-2029)
4.2 North America Anti-premature Ejaculation Drug Consumption Value (2018-2029)
4.3 Europe Anti-premature Ejaculation Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Anti-premature Ejaculation Drug Consumption Value (2018-2029)
4.5 South America Anti-premature Ejaculation Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Anti-premature Ejaculation Drug Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Anti-premature Ejaculation Drug Sales Quantity by Type (2018-2029)
5.2 Global Anti-premature Ejaculation Drug Consumption Value by Type (2018-2029)
5.3 Global Anti-premature Ejaculation Drug Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Anti-premature Ejaculation Drug Sales Quantity by Application (2018-2029)
6.2 Global Anti-premature Ejaculation Drug Consumption Value by Application (2018-2029)
6.3 Global Anti-premature Ejaculation Drug Average Price by Application (2018-2029)
7 North America
7.1 North America Anti-premature Ejaculation Drug Sales Quantity by Type (2018-2029)
7.2 North America Anti-premature Ejaculation Drug Sales Quantity by Application (2018-2029)
7.3 North America Anti-premature Ejaculation Drug Market Size by Country
7.3.1 North America Anti-premature Ejaculation Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Anti-premature Ejaculation Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Anti-premature Ejaculation Drug Sales Quantity by Type (2018-2029)
8.2 Europe Anti-premature Ejaculation Drug Sales Quantity by Application (2018-2029)
8.3 Europe Anti-premature Ejaculation Drug Market Size by Country
8.3.1 Europe Anti-premature Ejaculation Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Anti-premature Ejaculation Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Anti-premature Ejaculation Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anti-premature Ejaculation Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anti-premature Ejaculation Drug Market Size by Region
9.3.1 Asia-Pacific Anti-premature Ejaculation Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anti-premature Ejaculation Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Anti-premature Ejaculation Drug Sales Quantity by Type (2018-2029)
10.2 South America Anti-premature Ejaculation Drug Sales Quantity by Application (2018-2029)
10.3 South America Anti-premature Ejaculation Drug Market Size by Country
10.3.1 South America Anti-premature Ejaculation Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Anti-premature Ejaculation Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Anti-premature Ejaculation Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anti-premature Ejaculation Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anti-premature Ejaculation Drug Market Size by Country
11.3.1 Middle East & Africa Anti-premature Ejaculation Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anti-premature Ejaculation Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Anti-premature Ejaculation Drug Market Drivers
12.2 Anti-premature Ejaculation Drug Market Restraints
12.3 Anti-premature Ejaculation Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Anti-premature Ejaculation Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-premature Ejaculation Drug
13.3 Anti-premature Ejaculation Drug Production Process
13.4 Anti-premature Ejaculation Drug Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-premature Ejaculation Drug Typical Distributors
14.3 Anti-premature Ejaculation Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Anti-premature Ejaculation Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-premature Ejaculation Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Menarini Group Basic Information, Manufacturing Base and Competitors
Table 4. Menarini Group Major Business
Table 5. Menarini Group Anti-premature Ejaculation Drug Product and Services
Table 6. Menarini Group Anti-premature Ejaculation Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Menarini Group Recent Developments/Updates
Table 8. Ampio Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 9. Ampio Pharmaceuticals Inc Major Business
Table 10. Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Product and Services
Table 11. Ampio Pharmaceuticals Inc Anti-premature Ejaculation Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Ampio Pharmaceuticals Inc Recent Developments/Updates
Table 13. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Basic Information, Manufacturing Base and Competitors
Table 14. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Major Business
Table 15. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Product and Services
Table 16. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-premature Ejaculation Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments/Updates
Table 18. AdvaCare Basic Information, Manufacturing Base and Competitors
Table 19. AdvaCare Major Business
Table 20. AdvaCare Anti-premature Ejaculation Drug Product and Services
Table 21. AdvaCare Anti-premature Ejaculation Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. AdvaCare Recent Developments/Updates
Table 23. Global Anti-premature Ejaculation Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 24. Global Anti-premature Ejaculation Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 25. Global Anti-premature Ejaculation Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 26. Market Position of Manufacturers in Anti-premature Ejaculation Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 27. Head Office and Anti-premature Ejaculation Drug Production Site of Key Manufacturer
Table 28. Anti-premature Ejaculation Drug Market: Company Product Type Footprint
Table 29. Anti-premature Ejaculation Drug Market: Company Product Application Footprint
Table 30. Anti-premature Ejaculation Drug New Market Entrants and Barriers to Market Entry
Table 31. Anti-premature Ejaculation Drug Mergers, Acquisition, Agreements, and Collaborations
Table 32. Global Anti-premature Ejaculation Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 33. Global Anti-premature Ejaculation Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 34. Global Anti-premature Ejaculation Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 35. Global Anti-premature Ejaculation Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 36. Global Anti-premature Ejaculation Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 37. Global Anti-premature Ejaculation Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 38. Global Anti-premature Ejaculation Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 39. Global Anti-premature Ejaculation Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 40. Global Anti-premature Ejaculation Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 41. Global Anti-premature Ejaculation Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 42. Global Anti-premature Ejaculation Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 43. Global Anti-premature Ejaculation Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 44. Global Anti-premature Ejaculation Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 45. Global Anti-premature Ejaculation Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 46. Global Anti-premature Ejaculation Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 47. Global Anti-premature Ejaculation Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 48. Global Anti-premature Ejaculation Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 49. Global Anti-premature Ejaculation Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 50. North America Anti-premature Ejaculation Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 51. North America Anti-premature Ejaculation Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 52. North America Anti-premature Ejaculation Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 53. North America Anti-premature Ejaculation Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 54. North America Anti-premature Ejaculation Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 55. North America Anti-premature Ejaculation Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 56. North America Anti-premature Ejaculation Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 57. North America Anti-premature Ejaculation Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 58. Europe Anti-premature Ejaculation Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 59. Europe Anti-premature Ejaculation Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 60. Europe Anti-premature Ejaculation Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 61. Europe Anti-premature Ejaculation Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 62. Europe Anti-premature Ejaculation Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 63. Europe Anti-premature Ejaculation Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 64. Europe Anti-premature Ejaculation Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 65. Europe Anti-premature Ejaculation Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 66. Asia-Pacific Anti-premature Ejaculation Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 67. Asia-Pacific Anti-premature Ejaculation Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 68. Asia-Pacific Anti-premature Ejaculation Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 69. Asia-Pacific Anti-premature Ejaculation Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 70. Asia-Pacific Anti-premature Ejaculation Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 71. Asia-Pacific Anti-premature Ejaculation Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 72. Asia-Pacific Anti-premature Ejaculation Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 73. Asia-Pacific Anti-premature Ejaculation Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 74. South America Anti-premature Ejaculation Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 75. South America Anti-premature Ejaculation Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 76. South America Anti-premature Ejaculation Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 77. South America Anti-premature Ejaculation Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 78. South America Anti-premature Ejaculation Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 79. South America Anti-premature Ejaculation Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 80. South America Anti-premature Ejaculation Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 81. South America Anti-premature Ejaculation Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 82. Middle East & Africa Anti-premature Ejaculation Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 83. Middle East & Africa Anti-premature Ejaculation Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 84. Middle East & Africa Anti-premature Ejaculation Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Middle East & Africa Anti-premature Ejaculation Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Middle East & Africa Anti-premature Ejaculation Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 87. Middle East & Africa Anti-premature Ejaculation Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 88. Middle East & Africa Anti-premature Ejaculation Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 89. Middle East & Africa Anti-premature Ejaculation Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 90. Anti-premature Ejaculation Drug Raw Material
Table 91. Key Manufacturers of Anti-premature Ejaculation Drug Raw Materials
Table 92. Anti-premature Ejaculation Drug Typical Distributors
Table 93. Anti-premature Ejaculation Drug Typical Customers
List of Figures
Figure 1. Anti-premature Ejaculation Drug Picture
Figure 2. Global Anti-premature Ejaculation Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-premature Ejaculation Drug Consumption Value Market Share by Type in 2022
Figure 4. Serotonin Reuptake Inhibitors Examples
Figure 5. Phosphodiesterase Type 5 Inhibitors Examples
Figure 6. Local Anesthetic Examples
Figure 7. Others Examples
Figure 8. Global Anti-premature Ejaculation Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Anti-premature Ejaculation Drug Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Retail Pharmacy Examples
Figure 12. Clinic Examples
Figure 13. Online Pharmacy Examples
Figure 14. Global Anti-premature Ejaculation Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Anti-premature Ejaculation Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Anti-premature Ejaculation Drug Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Anti-premature Ejaculation Drug Average Price (2018-2029) & (US$/Unit)
Figure 18. Global Anti-premature Ejaculation Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Anti-premature Ejaculation Drug Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Anti-premature Ejaculation Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Anti-premature Ejaculation Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Anti-premature Ejaculation Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Anti-premature Ejaculation Drug Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Anti-premature Ejaculation Drug Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Anti-premature Ejaculation Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Anti-premature Ejaculation Drug Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Anti-premature Ejaculation Drug Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Anti-premature Ejaculation Drug Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Anti-premature Ejaculation Drug Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Anti-premature Ejaculation Drug Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Anti-premature Ejaculation Drug Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Anti-premature Ejaculation Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global Anti-premature Ejaculation Drug Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Anti-premature Ejaculation Drug Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Anti-premature Ejaculation Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America Anti-premature Ejaculation Drug Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Anti-premature Ejaculation Drug Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Anti-premature Ejaculation Drug Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Anti-premature Ejaculation Drug Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Anti-premature Ejaculation Drug Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Anti-premature Ejaculation Drug Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Anti-premature Ejaculation Drug Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Anti-premature Ejaculation Drug Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Anti-premature Ejaculation Drug Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Anti-premature Ejaculation Drug Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Anti-premature Ejaculation Drug Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Anti-premature Ejaculation Drug Consumption Value Market Share by Region (2018-2029)
Figure 56. China Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Anti-premature Ejaculation Drug Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Anti-premature Ejaculation Drug Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Anti-premature Ejaculation Drug Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Anti-premature Ejaculation Drug Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Anti-premature Ejaculation Drug Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Anti-premature Ejaculation Drug Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Anti-premature Ejaculation Drug Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Anti-premature Ejaculation Drug Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Anti-premature Ejaculation Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Anti-premature Ejaculation Drug Market Drivers
Figure 77. Anti-premature Ejaculation Drug Market Restraints
Figure 78. Anti-premature Ejaculation Drug Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Anti-premature Ejaculation Drug in 2022
Figure 81. Manufacturing Process Analysis of Anti-premature Ejaculation Drug
Figure 82. Anti-premature Ejaculation Drug Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source